세계의 뇌졸중 시장 보고서(2025년)

Stroke is a severe medical emergency caused by a blockage or reduction in blood flow to a portion of the brain, which prevents the delivery of vital oxygen and nutrients to brain tissue. This interruption can cause brain cells to die within minutes, leading to sudden impairments like speech difficulties, paralysis, or cognitive dysfunction, and may result in lasting disability or death if immediate treatment is not administered.

The primary types of stroke include ischemic stroke, transient ischemic attack (TIA), and hemorrhagic stroke. Ischemic stroke occurs when a blood clot or other blockage obstructs blood flow to the brain, cutting off oxygen and nutrients. Various diagnoses and treatments are tailored for different gender groups, including male and female patients, and these services are distributed through channels such as direct providers, retail outlets, and online platforms. The main users of these services are hospitals and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The stroke market research report is one of a series of new reports from The Business Research Company that provides stroke market statistics, including the stroke industry global market size, regional shares, competitors with the stroke market share, detailed stroke market segments, market trends, and opportunities, and any further data you may need to thrive in the stroke industry. This stroke market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The stroke market size has grown rapidly in recent years. It will grow from $35.92 billion in 2024 to $39.72 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historical period is driven by the rising prevalence of cardiovascular diseases, an expanding elderly population, improved awareness of stroke symptoms, development of hospital infrastructure, and enhanced government support initiatives.

The stroke market size is expected to see rapid growth in the next few years. It will grow to $58.81 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The anticipated growth during the forecast period is driven by the increasing use of telemedicine, rising demand for minimally invasive treatments, greater emphasis on early diagnosis, expanding healthcare access in emerging markets, and growing investment in stroke care technologies. Key trends expected include advancements in AI-powered diagnostic tools, ongoing innovations in neurorehabilitation, development of new thrombolytic medications, personalized stroke treatment approaches, and progress in regenerative therapy research.

The rising number of hypertension cases is expected to drive the growth of the stroke market in the coming years. Hypertension, or high blood pressure, occurs when the force of blood against artery walls remains consistently elevated. The increase in hypertension cases is largely attributed to rising obesity rates, as excess body weight puts additional strain on the heart and blood vessels, leading to higher blood pressure over time. Hypertension contributes to stroke by placing excessive pressure on blood vessel walls, which can result in the weakening, narrowing, or rupture of arteries in the brain. For example, in January 2025, the American Heart Association, a US-based nonprofit, reported 131,454 deaths primarily linked to high blood pressure in 2022. Additionally, in January 2024, the same organization reported 124,508 deaths primarily related to high blood pressure in 2021. Thus, the growing prevalence of hypertension is fueling the expansion of the stroke market.

Key players in the stroke market are concentrating on innovative stroke intervention technologies, such as flow-regulated large-bore access devices, to improve procedural accuracy and outcomes in complex neurovascular treatments like mechanical thrombectomy. Flow-regulated large-bore access involves a catheter design that combines a wide inner diameter for device delivery with integrated blood flow control, allowing for safer and more effective navigation during neurovascular procedures. For instance, in February 2025, Johnson & Johnson MedTech, a US-based medical technology firm, introduced the CEREGLIDE 92 Catheter System, a next-generation.092" catheter designed to enhance access and flow regulation during mechanical thrombectomy for acute ischemic stroke. This system aids physicians in navigating brain anatomy and restoring blood flow more efficiently. The device includes the INNERGLIDE 9 delivery aid for smooth catheter insertion and BRITE-LINE technology for improved visibility during procedures. Its TruCourse flexible tip facilitates navigation through complex cerebral vessels, boosting treatment success and patient outcomes, while also promoting sustainability through electronic instructions, reducing environmental impact.

In May 2025, Merck KGaA, a US-based science and technology company, acquired ApTOLL from aptaTargets for an undisclosed sum. Through this acquisition, Merck KGaA aims to broaden its neurology portfolio by advancing the development and commercialization of ApTOLL, an innovative therapy targeting acute ischemic stroke with the potential to reduce inflammation and brain damage, thereby improving patient outcomes. AptaTargets SL is a Spain-based biotechnology firm focused on developing novel treatments for acute neurological conditions, especially acute ischemic stroke.

Major players in the stroke market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Medtronic plc, Fresenius SE & Co. KGaA, Stryker Corporation, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceuticals USA Inc., Daiichi Sankyo Company Limited, Amneal Pharmaceuticals LLC, Lupin Limited, MicroPort Scientific Corporation, Penumbra Inc., and NeuroVasc Technologies Inc.

North America was the largest region in the stroke market in 2024, and it is expected to be the fastest-growing region in the forecast period. The regions covered in stroke report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the stroke market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stroke market includes revenues earned by entities by providing services such as emergency medical services, imaging services, and blood pressure management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stroke Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stroke market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stroke ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stroke market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Ischemic Stroke; Transient Ischemic Attack (TIA); Hemorrhagic Stroke
• 2) By Diagnosis And Treatment: Diagnosis; Treatment
• 3) By Gender: Female; Male
• 4) By Distribution Channel: Direct; Retail; Online
• 5) By End User: Hospitals; Clinics
• Subsegments:
• 1) By Ischemic Stroke: Thrombotic Stroke; Embolic Stroke; Cryptogenic Stroke; Lacunar Stroke
• 2) By Transient Ischemic Attack (TIA): Carotid Artery Transient Ischemic Attack (TIA); Cardiac Source Transient Ischemic Attack (TIA); Undetermined Cause Transient Ischemic Attack (TIA)
• 3) By Hemorrhagic Stroke: Intracerebral Hemorrhage (ICH); Subarachnoid Hemorrhage (SAH); Subdural Hemorrhage; Epidural Hemorrhage
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories; Medtronic plc; Fresenius SE & Co. KGaA; Stryker Corporation; Boehringer Ingelheim International GmbH; Viatris Inc.; Teva Pharmaceuticals USA Inc.; Daiichi Sankyo Company Limited; Amneal Pharmaceuticals LLC; Lupin Limited; MicroPort Scientific Corporation; Penumbra Inc.; NeuroVasc Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stroke Market Characteristics

3. Stroke Market Trends And Strategies

4. Stroke Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Stroke Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stroke PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stroke Market Growth Rate Analysis
• 5.4. Global Stroke Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stroke Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stroke Total Addressable Market (TAM)

6. Stroke Market Segmentation

• 6.1. Global Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ischemic Stroke
• Transient Ischemic Attack (TIA)
• Hemorrhagic Stroke
• 6.2. Global Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Treatment
• 6.3. Global Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Female
• Male
• 6.4. Global Stroke Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct
• Retail
• Online
• 6.5. Global Stroke Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• 6.6. Global Stroke Market, Sub-Segmentation Of Ischemic Stroke, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombotic Stroke
• Embolic Stroke
• Cryptogenic Stroke
• Lacunar Stroke
• 6.7. Global Stroke Market, Sub-Segmentation Of Transient Ischemic Attack (TIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carotid Artery Transient Ischemic Attack (TIA)
• Cardiac Source Transient Ischemic Attack (TIA)
• Undetermined Cause Transient Ischemic Attack (TIA)
• 6.8. Global Stroke Market, Sub-Segmentation Of Hemorrhagic Stroke, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intracerebral Hemorrhage (ICH)
• Subarachnoid Hemorrhage (SAH)
• Subdural Hemorrhage
• Epidural Hemorrhage

7. Stroke Market Regional And Country Analysis

• 7.1. Global Stroke Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stroke Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stroke Market

• 8.1. Asia-Pacific Stroke Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stroke Market

• 9.1. China Stroke Market Overview
• 9.2. China Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stroke Market

• 10.1. India Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stroke Market

• 11.1. Japan Stroke Market Overview
• 11.2. Japan Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stroke Market

• 12.1. Australia Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stroke Market

• 13.1. Indonesia Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stroke Market

• 14.1. South Korea Stroke Market Overview
• 14.2. South Korea Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stroke Market

• 15.1. Western Europe Stroke Market Overview
• 15.2. Western Europe Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stroke Market

• 16.1. UK Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stroke Market

• 17.1. Germany Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stroke Market

• 18.1. France Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stroke Market

• 19.1. Italy Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stroke Market

• 20.1. Spain Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stroke Market

• 21.1. Eastern Europe Stroke Market Overview
• 21.2. Eastern Europe Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stroke Market

• 22.1. Russia Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stroke Market

• 23.1. North America Stroke Market Overview
• 23.2. North America Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stroke Market

• 24.1. USA Stroke Market Overview
• 24.2. USA Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stroke Market

• 25.1. Canada Stroke Market Overview
• 25.2. Canada Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stroke Market

• 26.1. South America Stroke Market Overview
• 26.2. South America Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stroke Market

• 27.1. Brazil Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stroke Market

• 28.1. Middle East Stroke Market Overview
• 28.2. Middle East Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stroke Market

• 29.1. Africa Stroke Market Overview
• 29.2. Africa Stroke Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stroke Market, Segmentation By Diagnosis And Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stroke Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stroke Market Competitive Landscape And Company Profiles

• 30.1. Stroke Market Competitive Landscape
• 30.2. Stroke Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Stroke Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca plc
• 31.3. Abbott Laboratories
• 31.4. Medtronic plc
• 31.5. Fresenius SE & Co. KGaA
• 31.6. Stryker Corporation
• 31.7. Boehringer Ingelheim International GmbH
• 31.8. Viatris Inc.
• 31.9. Teva Pharmaceuticals USA Inc.
• 31.10. Daiichi Sankyo Company Limited
• 31.11. Amneal Pharmaceuticals LLC
• 31.12. Lupin Limited
• 31.13. MicroPort Scientific Corporation
• 31.14. Penumbra Inc.
• 31.15. NeuroVasc Technologies Inc.

32. Global Stroke Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stroke Market

34. Recent Developments In The Stroke Market

35. Stroke Market High Potential Countries, Segments and Strategies

• 35.1 Stroke Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stroke Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stroke Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer